Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis
- PMID: 20596827
- PMCID: PMC4224686
- DOI: 10.1007/s11427-010-0059-7
Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis
Abstract
A robust animal model for "hypothesis-testing/mechanistic" research in human immunology and immuno-pathology should meet the following criteria. First, it has well-studied hemato-lymphoid organs and target cells similar to those of humans. Second, the human pathogens establish infection and lead to relevant diseases. Third, it is genetically inbred and can be manipulated via genetic, immunological and pharmacological means. Many human-tropic pathogens such as HIV-1 fail to infect murine cells due to the blocks at multiple steps of their life cycle. The mouse with a reconstituted human immune system and other human target organs is a good candidate. A number of human-mouse chimeric models with human immune cells have been developed in the past 20 years, but most with only limited success due to the selective engraftment of xeno-reactive human T cells in hu-PBL-SCID mice or the lack of significant human immune responses in the SCID-hu Thy/Liv mouse. This review summarizes the current understanding of HIV-1 immuno-pathogenesis in human patients and in SIV-infected primate models. It also reviews the recent progress in the development of humanized mouse models with a functional human immune system, especially the recent progress in the immunodeficient mice that carry a defective gammaC gene. NOD/SCID/gammaC(-/-) (NOG or NSG) or the Rag2(-/-)gammaC(-/-) double knockout (DKO) mice, which lack NK as well as T and B cells (NTB-null mice), have been used to reconstitute a functional human immune system in central and peripheral lymphoid organs with human CD34(+) HSC. These NTB-hu HSC humanized models have been used to investigate HIV-1 infection, immuno-pathogenesis and therapeutic interventions. Such models, with further improvements, will contribute to study human immunology, human-tropic pathogens as well as human stem cell biology in the tissue development and function in vivo.
Comment in
-
Recent progress of immunology research in China.Sci China Life Sci. 2011 Nov;54(11):1068-70. doi: 10.1007/s11427-011-4248-9. Epub 2011 Dec 16. Sci China Life Sci. 2011. PMID: 22173316 Free PMC article. No abstract available.
Similar articles
-
Humanized Mice Engrafted With Human HSC Only or HSC and Thymus Support Comparable HIV-1 Replication, Immunopathology, and Responses to ART and Immune Therapy.Front Immunol. 2018 Apr 19;9:817. doi: 10.3389/fimmu.2018.00817. eCollection 2018. Front Immunol. 2018. PMID: 29725337 Free PMC article.
-
Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.J Virol. 1997 Mar;71(3):2417-24. doi: 10.1128/JVI.71.3.2417-2424.1997. J Virol. 1997. PMID: 9032379 Free PMC article.
-
Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.Virology. 2008 Apr 10;373(2):342-51. doi: 10.1016/j.virol.2007.11.020. Epub 2008 Jan 18. Virology. 2008. PMID: 18207484 Free PMC article.
-
The utilization of humanized mouse models for the study of human retroviral infections.Retrovirology. 2009 Aug 12;6:76. doi: 10.1186/1742-4690-6-76. Retrovirology. 2009. PMID: 19674458 Free PMC article. Review.
-
SCID-hu mice: a model for studying disseminated HIV infection.Semin Immunol. 1996 Aug;8(4):223-31. doi: 10.1006/smim.1996.0028. Semin Immunol. 1996. PMID: 8883145 Review.
Cited by
-
Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model.Onco Targets Ther. 2019 Sep 20;12:7773-7784. doi: 10.2147/OTT.S222097. eCollection 2019. Onco Targets Ther. 2019. PMID: 31571927 Free PMC article.
-
The clinical and immunological performance of 28 days survival model of cecal ligation and puncture in humanized mice.PLoS One. 2017 Jul 17;12(7):e0180377. doi: 10.1371/journal.pone.0180377. eCollection 2017. PLoS One. 2017. PMID: 28715505 Free PMC article.
-
Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research.J Transl Med. 2016 Feb 9;14:44. doi: 10.1186/s12967-016-0807-y. J Transl Med. 2016. PMID: 26861779 Free PMC article. Review.
-
Rodent models for HIV-associated neurocognitive disorders.Trends Neurosci. 2012 Mar;35(3):197-208. doi: 10.1016/j.tins.2011.12.006. Epub 2012 Feb 1. Trends Neurosci. 2012. PMID: 22305769 Free PMC article. Review.
-
Brain Invasion by CD4(+) T Cells Infected with a Transmitted/Founder HIV-1BJZS7 During Acute Stage in Humanized Mice.J Neuroimmune Pharmacol. 2016 Sep;11(3):572-83. doi: 10.1007/s11481-016-9654-0. Epub 2016 Feb 2. J Neuroimmune Pharmacol. 2016. PMID: 26838362
References
-
- United Nations Programme on HIV/AIDS. Global Facts & Figures [PDF on Internet] 2009 Available from: http://data.unaids.org/pub/factsheet/2009/20091124_fs_global_en.pdf.
-
- Ganick DJ, Sarnwick RD, Shahidi NT, Manning DD. Inability of intravenously injected monocellular suspensions of human bone marrow to establish in the nude mouse. Int Arch Allergy Appl Immunol. 1980;62:330–333. - PubMed
-
- Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301:527–530. - PubMed
-
- Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 1988;335:256–259. - PubMed
-
- McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988;241:1632–1639. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous